Who cares about pharma ESG efforts? Patients and patient groups do — and they want more, survey finds
Even as environmental, social and governance (ESG) efforts have fallen out of favor among some investors and business leaders, the majority of patients are still …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
